Projects Archive — Page 2 of 6 — DPS Group

Abbvie, Biologics Cell Culture Suite

DPS was engaged to design a new single use 3,000 SF cell culture suite featuring a fully single-use process pathway after completing the front-end planning phase.

Massachusetts

AE manufacturing equipment installation design, confidential client

DPS completed the engineering and design phase for the largest private investment manufacturing equipment installation project in the history of the Irish State over a 16 month period.

Ireland

Alexion, Purification Facility

Concept, Basic and Detailed Design and CQV for a multi-product single use purification facility housed in a standalone building, with black utilities fed from the existing CUB.

Ireland

Arranta Bio, Microbiome Manufacturing Facility

DPS Group and TRIA provided design services for the renovation and fit-out of a former warehouse space into an 80,000SF cGMP development and manufacturing facility for novel therapies targeting diseases linked to the human microbiome.

Massachusetts

Avecia, Oligo manufacturing facility expansion

DPS provided detailed design services to assist Avecia in increasing its oligonucleotide API manufacturing capacity with a 20,000SF expansion.

Massachusetts

BIM, federated model management, confidential client

DPS is engaged as to manage the federated model on a 1.2 million sq.ft. solar photovoltaic (PV) manufacturing facility.

New York

Biogen, Purification/Harvest (P2P2) & Train 3 Projects

DPS Group successfully secured the C&Q Managed Services Contract for the new Purification / Harvest Suite (P2/H2) and the Train 3 Projects at Biogen Idec, Hillerød, Denmark.

Denmark

BioMarin, Fed Batch Readiness Project

DPS was appointed as the Architectural and Engineering partner for BioMarin’s “Fed Batch Facility Readiness Project”.

Ireland

bluebird bio, Clinical Manufacturing Facility

DPS was retained as the design partner to perform the Concept Design for a cGMP clinical manufacturing facility/Pilot Plant for a CAR-T cell therapy product.

Massachusetts

BMS, Cell Therapy Facility

The CAR-T Cell Therapy Facility (CTF) project will be a multi-product facility consisting of 4 production and 2 filling suites with supporting utilities labs, offices and logistic facilities with an overall area of ~20,000m².

Netherlands

BMS, Hydrogenation Facility

DPS executed full EPCMV project services to deliver a cGMP upgrade to an existing Buss loop technology based Hydrogenation facility in the heart of the BMS facility in Swords.

Leinster

Brammer Bio, Gene Therapy cGMP Manufacturing and QC Operations Facility

DPS provided detailed design services to assist Brammer in developing a new cGMP manufacturing and QC operations facility.

Massachusetts

Brammer Bio, Viral Vector Manufacturing Facility

Having successfully completed several gene therapy projects, Brammer Bio hired DPS to work on the renovation and expansion of its GMP facility.

Massachusetts

Capua BioServices, mRNA and Biologics Facility

DPS is executing a feasibility study for Capua BioServices for a manufacturing area that will allow them to enter in to the CDMO market for microbial parenteral biologic substances and mRNA vaccines production.

Italy

Codiak, Clinical Manufacturing Facility

The goals of this project were to assess current process manufacturing design and capabilities and identify future space and organizational needs.

Massachusetts

Confidential Client, Lab & HQ Projects

DPS was awarded the contract for the development from Concept through Basic Engineering, Permitting, Detailed Engineering, Procurement and Construction management for their new 34,000 m² Worldwide Headquarters in Belgium.

Belgium

Confidential Client, New Production Facility

DPS is implementing new production units in an existing and unused building, in partnership with Talboom

Belgium

Confidential Client, Novel Vaccines Facility

DPS was contracted to develop a pre-concept (feasibility) design for a multi-product mRNA vaccine manufacturing facility, comprising Drug Substance (DNA template and mRNA Synthesis) and Fill Finish

United Kingdom

Confidential Client, Oligonucleotide Development Pilot Plant

DPS was engaged to develop a feasibility study to locate an oligonucleotide development and scale up facility at an existing site within the client network.

Mainland Europe (EU)

Confidential solar manufacturing client third party commissioning agent

DPS is engaged as the Owner’s Third Party Commissioning Agent on a 1.2 million sq.ft. solar photovoltaic (PV) manufacturing facility.

New York

CSL Behring, Multi-Purpose Biologics Facility (MPF)

CSL plan to build a Multi-Purpose Biologics Facility (MFP) to support their manufacturing strategy; particularly to develop and support growth in gene and cell therapy.

Switzerland

ElevateBio, Clinical Manufacturing Facility

DPS was selected to provide professional architectural and engineering services to develop a full design package for ElevateBio’s Massachusetts-based clinical manufacturing facility.

Massachusetts

Evelo Biosciences, Microbiome Clinical Manufacturing Facility

DPS was engaged by Evelo Biosciences to aid in realizing a new Microbiome Clinical Manufacturing Suite.

Massachusetts

GSK, New Manufacturing Building

Green field cGMP BSL-3 vaccine manufacturing facility. At the end of the detailed design phase, GSK decided to build an integrated team for the Construction and Commissioning phase.

Belgium

GSK, Revamping Of A Production Area

Revamping of 1 500 m2 of classified areas dedicated to vials and syringes filling activities in the Building W16 in Wavre.

Belgium

Homology, Viral Vector Manufacturing Facility & QC Operations

To support its rapid transition into clinical development, the client is planning to build a new cGMP Manufacturing/ Pilot and QC Operations facility.

Massachusetts

inviCRO, New Laboratories

DPS carried out the architectural and engineering design for a lab fit-out project for inviCRO in Boston, Massachusetts.

Massachusetts

Janssen Biologics, Single Use Cell Culture Facility

DPS executed the full project engineering design for a new single use Cell Culture Suite at Janssen Biologics site in Cork, Ireland.

Ireland

Janssen, Viral Vector Production Facility

DPS Group developed a concept design for a large scale EMEA viral vector production facility in Sassenheim, the Netherlands.

Netherlands

Janssen, VLF Expansion

BSL-2 vaccines production facility expansion for JBV, Leiden to accommodate the production of the COVID-19 vaccines from 2021 on.

Netherlands

Lonza Biologics, Multi-product Cell Therapy Manufacturing Suite

Lonza Biologics contracted DPS Group to retrofit an existing manufacturing area to convert the space to a multi-product cell therapy manufacturing suite at its Portsmouth, NH facility.

New Hampshire

Moderna Therapeutics, Clinical Manufacturing Facility

DPS and TRIA (a DPS Group company) were engaged by Moderna to provide full EPCMV and architectural design services to complete its new 200,000 sf cGMP clinical manufacturing facility in Norwood, MA.

Massachusetts

Moderna Therapeutics, GMP Manufacturing Facility Retrofit

Moderna is a leader in the development of messenger RNA therapeutics. The company recently acquired a 13,000 sf space to expand their existing operations.

Massachusetts

MSD, Sterile Manufacturing Facility Upgrade

DPS secured the Concept Study/Basis of Design Studies, Detailed Design and Qualification for the OPS1 Facility upgrade.

Ireland

MSD, New Vaccines Fill Finish Facility

DPS successfully secured the C&Q client led team for the €220m Greenfield vaccines facility at MSD, Carlow, Ireland.

Leinster

MSD, Tissue Culture Boxmeer Expansion

This project allows MSD to expand the Tissue Culture production facility for their Vaccine production operations in Boxmeer the Netherlands.

Netherlands

MSD, V116 Project

DPS was awarded the BoD and EPCMV aspects for a major upgrade at MSD, Brinny facility, to provide vaccine production capability with alterations and extensions to a permitted pharmaceutical production building, for pharmaceutical vaccine production use.

Ireland

Mustang Bio, Cell Processing Facility

DPS Group executed full BOD, Detailed Design and Construction Administration for Mustang Bio’s Cell Processing Facility in Worcester, MA.

Massachusetts

Novartis, Project Next

DPS were engaged to provide the facilities detailed design for Phase 1 of a CAR-T phased manufacturing capacity for Novartis in Stein.

Switzerland

Pfizer, COVID Vaccine Readiness Project

To answer the global COVID-19 pandemic Pfizer expanded its Fill & Finish capacity at their site in Puurs. DPS supported Pfizer with multiple sub-projects.

Belgium

Pfizer, Multi-product Kilo Scale API Facility

DPS was awarded the complete architectural and engineering design for a New Products Facility (NPI) at Pfizer, Ringaskiddy site in Cork, Ireland.

Ireland

Pfizer, New Sterile Vaccine Fill Finish Facility

DPS executed engineering, design and procurement for a new 5,000 sq.m vial fill finish facility at Pfizer Puurs, Belgium.

Belgium

Pfizer, Sterile Manufacturing Expansion

DPS was engaged to carry out a Site Master Plan and Concept Study for a new sterile manufacturing expansion for a vial filling and lyophilisation facility.

Spain

Pfizer, Sterile Manufacturing Facility, Site Master Planning, Spain

DPS were engaged to carry out a Site Master Plan and Feasibility Study for the Pfizer Algete site in Spain for a future sterile manufacturing expansion for a range of product formats;

Spain

Replimune, Clinical Manufacturing Facility

DPS was hired to provide engineering and design services for a new cGMP manufacturing facility having completed the process definition and test fit phases.

Massachusetts

Sangamo Therapeutics, CAR-Treg Clinical Facility

DPS was engaged to develop a feasibility study to assess the opportunity to retrofit an existing building with a CAR-Treg cell therapy clinical manufacturing facility.

France

Sanofi (Genzyme) 31NYA Pilot Plant, MA

Genzyme Biologics R&D is developing an integrated continuous bioprocessing platform for recombinant therapeutic proteins.

Massachusetts

Sanofi, Biologics Facility Upgrade & Remediation Projects

Sanofi Genzyme’s Allston Landing Facility (ALF) is the main manufacturing facility for Cerezyme, one of the company’s orphan drug products.

Massachusetts

Sarepta Therapeutics, Gene Therapy Centre of Excellence and Manufacturing Network

USA

Semma Therapeutics, R&D and Clinical Manufacturing Facility

DPS completed the MEP Design for the space to accommodate R&D labs and support areas in Semma’s new Cambridge, MA location.

Massachusetts

Seres Therapeutics, Laboratory and Clinical Manufacturing Facility

This project was a fit-out of approximately 85,000 sf of cGMP pilot plant, laboratory, and office space at 200 Sidney Street in Cambridge, Massachusetts.

Massachusetts

Solar program management US, confidential client

DPS is engaged as the Program Manager on a 1.2 million sq.ft. solar photovoltaic (PV) manufacturing facility.

New York

SORAA, LED manufacturing facility

The project scope is for a new Cleanroom Manufacturing Facility, support and office area of 80,000 sq.ft.

New York

UMass MAB, Laboratory, Development and Early Phase Cell Culture Manufacturing Facility, MA

DPS provided full multidisciplinary A/E design for a new, 32,000 sq. ft. biopharmaceutical facility. The greenfield facility in Dartmouth MA, is the anchor tenant of a planned 300-acre biotechnology park.

Massachusetts

Vertex, Gene / Cell Therapy Manufacturing Facility

DPS was engaged to assist Vertex in determining feasibility to build a multi-product, flexible Gene / Cell Therapy Manufacturing facility in Massachusetts.

Massachusetts

Wacker Biotech, mRNA Production & Microbial Process Development Laboratory

Wacker Biotech is a contract manufacturer of therapeutic proteins, vaccines and live microbial products. Their Amsterdam GMP manufacturing facility intends to expand its mRNA production capacity and redesign their process development laboratory.

Netherlands

Wafer fabrication manufacturing equipment de-installation, confidential client

To facilitate for a major Next Generation 300mm Manufacturing Equipment Installation project for a Confidential Client in Ireland, DPS were engaged to manage and execute the entire Equipment De-installation Program.

Ireland

Wafer Fabrication Manufacturing Equipment Installation, Confidential Client

DPS completed a Wafer Fabrication Manufacturing Equipment Installation project for a confidential client in Ireland over a 24 month period that required a full de-installation, upgrade and reinstallation of next generation process technology.

Ireland

Wafer fabrication manufacturing facility 3D scanning Project, confidential client

To facilitate for a major Next Generation 300mm Manufacturing Equipment Installation project for a Confidential Client in Ireland, DPS were engaged to manage and execute the entire Equipment De-installation Program

Ireland

Wave Life Sciences, Oligonucleotide Production Facility

WAVE Life Sciences wanted a facility to support the process development and clinical manufacturing of their proprietary oligonucleotide products.

Massachusetts

New Sterile Vaccine Fill Finish Facility, Pfizer

DPS executed engineering, design and procurement for a new 5,000 sq.m vial fill finish facility at Pfizer Puurs, Belgium.

Belgium

Zoetis, Drug Substance Scale Up

Zoetis is a global animal health company delivering quality medicines and vaccines, complemented by diagnostic products, genetic tests, biodevices and a range of services.

Ireland

Zoetis, New Fill Finish Building

The project goal was to build a new Fill Finish facility for the Zoetis Louvain-la-Neuve (LLN ) in Belgium to support additional vaccine production.

Belgium

All Projects